SCHEMBL10154084

SCHEMBL10154084

CC(C)(C)c1ccc(-c2cc(-c3ccc(C(C)(C)C)cc3)cc(-c3ccnc4ccccc34)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 4/20 0.49
PIK3CA P42336 1/20 0.44
KDR P35968 1/20 0.44
AURKA O14965 1/20 0.43
TTK P33981 1/20 0.43
AURKB Q96GD4 1/20 0.43
INCENP Q9NQS7 1/20 0.43
KIF11 P52732 2/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
AAK1 Q2M2I8 6/20 0.42
TNKS O95271 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
HTR2B P41595 1/20 0.42
MTNR1A P48039 1/20 0.42
KCNH2 Q12809 1/20 0.42
GRM4 Q14833 1/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28925687 0.91 KDR (0.48) ACVR1PIK3CAKDRAURKATTK
SCHEMBL25878119 0.80 KDR (0.56) ACVR1KDRKIF11CA12CA1
SCHEMBL27430955 0.77 ACVR1 (0.52) ACVR1PIK3CAAURKATTKAURKB
SCHEMBL18327517 0.77 PIK3CA (0.51) ACVR1PIK3CAAURKATTKAURKB
SCHEMBL24601024 0.76 GRM4 (0.50) ACVR1PIK3CAKDRAURKBKIF11
SCHEMBL12074333 0.76 PIK3CA (0.65) ACVR1PIK3CAKDRAURKATTK
SCHEMBL31222481 0.75 TGFBR1 (0.52) ACVR1PIK3CAKIF11AAK1TNKS
SCHEMBL18327314 0.75 PIK3CA (0.49) ACVR1PIK3CAAURKATTKAURKB
SCHEMBL28293866 0.75 PIK3CA (0.46) ACVR1PIK3CAKIF11MEN1KMT2A
SCHEMBL19991864 0.74 PIK3CA (0.59) ACVR1PIK3CAAURKATTKAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041203-A1 METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041203-A1 METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM MICA, CD4, CLTC ACVR1 4739/4885PIK3CA 3535/4885KDR 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.